BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27996269)

  • 1. Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles.
    Bhunia SS; Misra A; Khan IA; Gaur S; Jain M; Singh S; Saxena A; Hohlfield T; Dikshit M; Saxena AK
    J Med Chem; 2017 Jan; 60(1):322-337. PubMed ID: 27996269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling studies in explaining the higher GPVI antagonistic activity of the racemic 2-(4-methoxyphenylsulfonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide than its enantiomers.
    Bhunia SS; Saxena AK
    SAR QSAR Environ Res; 2017 Oct; 28(10):783-799. PubMed ID: 29135287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel antiplatelet agents by targeting Glycoprotein VI: A combined virtual screening study.
    Olğaç S; Olğaç A; Yenicesu İ; Ozkan Y
    Bioorg Chem; 2022 Apr; 121():105661. PubMed ID: 35182883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
    Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convulxin forms a dimer in solution and can bind eight copies of glycoprotein VI: implications for platelet activation.
    Horii K; Brooks MT; Herr AB
    Biochemistry; 2009 Apr; 48(13):2907-14. PubMed ID: 19209849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan.
    Jiang P; Loyau S; Tchitchinadze M; Ropers J; Jondeau G; Jandrot-Perrus M
    PLoS One; 2015; 10(6):e0128744. PubMed ID: 26052700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
    Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI.
    Ono K; Ueda H; Yoshizawa Y; Akazawa D; Tanimura R; Shimada I; Takahashi H
    J Med Chem; 2010 Mar; 53(5):2087-93. PubMed ID: 20158191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convulxin-induced platelet adhesion and aggregation: involvement of glycoproteins VI and IaIIa.
    Jandrot-Perrus M; Lagrue AH; Leduc M; Okuma M; Bon C
    Platelets; 1998; 9(3-4):207-11. PubMed ID: 16793703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptide.
    Bishton MJ; Gardiner EE; Harrison SJ; Prince HM; Johnstone RW
    Thromb Res; 2013 Jun; 131(6):514-20. PubMed ID: 23642854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
    Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
    Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
    Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
    FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
    Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
    FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.
    Mangin PH; Tang C; Bourdon C; Loyau S; Freund M; Hechler B; Gachet C; Jandrot-Perrus M
    J Pharmacol Exp Ther; 2012 Apr; 341(1):156-63. PubMed ID: 22238212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of a humanized inhibitory anti-platelet glycoprotein VI phage antibody from a phage antibody library.
    Liu Q; Zhang C; Yu L; Shi Y; Zhang L; Peng J; Ji X; Hou M
    Hematology; 2016 Jan; 21(1):60-7. PubMed ID: 26330203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
    Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
    Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cape Chacma baboon is not suitable for evaluating human targeted anti-GPVI agents.
    Janse van Rensburg WJ; Badenhorst PN; Roodt JP
    Platelets; 2015; 26(6):552-7. PubMed ID: 25165849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.